Get the Stockscreener App
0.612
0.16%
0.001
After Hours:
.61
-0.002
-0.33%
Nanovibronix Inc stock is traded at $0.612, with a volume of 35,358.
It is up +0.16% in the last 24 hours and up +7.37% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
See More
Previous Close:
$0.611
Open:
$0.64
24h Volume:
35,358
Relative Volume:
1.02
Market Cap:
$1.70M
Revenue:
$2.28M
Net Income/Loss:
$-3.71M
P/E Ratio:
-0.1821
EPS:
-3.36
Net Cash Flow:
$-3.60M
1W Performance:
-8.67%
1M Performance:
+7.37%
6M Performance:
-32.00%
1Y Performance:
-68.93%
1-Day Range:
$0.58
$0.64
1-Week Range:
$0.55
$0.67
52-Week Range:
$0.52
$2.06
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
525 EXECUTIVE BLVD, ELMSFORD
Nanovibronix Inc Stock (NAOV) Latest News
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com India
NanoVibronix extends CEO and CFO contracts with new terms - Investing.com
NanoVibronix Secures Leadership with New Executive Agreements - TipRanks
NanoVibronix explores UroShield distribution in Israel By Investing.com - Investing.com Canada
NanoVibronix explores UroShield distribution in Israel - Investing.com
NanoVibronix explores UroShield distribution in Israel - Investing.com India
NAOVNanoVibronix, Inc. Latest Stock News & Market Updates - StockTitan
NanoVibronix Signs Letter of Intent with Potential New Distributor - StockTitan
Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m - PMLiVE
Audit raises transparency concerns in IPO utilisation - The Business Post
UBC’s NanoVation Therapeutics inks US$600 million deal with Novo Nordisk - BCBusiness
Novo Nordisk and NanoVation Inked $600M+ Genetic Medicine Deal - Inside Precision Medicine
NanoVation partners with Novo Nordisk to develop genetic medicines - World Pharmaceutical Frontiers
Vancouver biotech inks $800M partnership with Novo Nordisk - Business in Vancouver
NanoVation inks genetic medicines deal with Novo Nordisk - The Pharma Letter
Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver - Fierce Biotech
NanoVibronix (NASDAQ:NAOV) Stock Price Passes Below 50 Day Moving Average of $0.66 - Defense World
NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.70 - Defense World
NanoVibronix (STU:56R0) 5-Day RSI : 39.10 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Momentum Rank : 4 (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix (STU:56R0) Float Percentage Of Total Shares Ou - GuruFocus.com
NanoVibronix (STU:56R0) PE Ratio without NRI : At Loss (As of Aug. 22, 2024) - GuruFocus.com
NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - StockTitan
NAOV (NanoVibronix) Debt-to-Revenue : 0.03 (As of Mar. 2024) - GuruFocus.com
NAOV (NanoVibronix) EPS (Basic) : $-1.69 (TTM As of Mar. 2024) - GuruFocus.com
NanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023) - Yahoo Finance
NanoVibronix (NASDAQ:NAOV) Stock Price Crosses Below 50 Day Moving Average of $0.72 - Defense World
NanoVibronix (STU:56R0) Short-Term Capital Lease Obligation : €0.04 Mil (As of Jun. 2024) - GuruFocus.com
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.76 - Defense World
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com Australia
NanoVibronix stock hits 52-week low at $0.58 amid market challenges - Investing.com Canada
NanoVibronix Inc (NAOV) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Metrics Check: NanoVibronix Inc (NAOV)’s Ratios for Trailing Twelve Months - The Dwinnex
Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Increases By 57.2% - Defense World
NanoVibronix (NASDAQ:NAOV) Share Price Crosses Below Fifty Day Moving Average of $0.76 - Defense World
Nanovibronix Inc (NAOV-Q) QuotePress Release - The Globe and Mail
NanoVibronix Announces Reverse Stock Split - Quantisnow
NanoVibronix Reports Progress on Three Clinical Trials - Yahoo News UK
NanoVibronix (NASDAQ:NAOV) Stock Passes Below Fifty Day Moving Average of $0.79 - Defense World
NanoVibronix (NASDAQ:NAOV) Shares Pass Below 50 Day Moving Average of $0.80 - Defense World
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's ... - Yahoo Movies UK
NanoVibronix CEO Brian Murphy and Former Yankees Pitcher Mariano Rivera to Appear on Fox Business Network's ... - Yahoo News UK
NanoVibronix Issues Letter to Stockholders - citybiz
NanoVibronix Shares Q1 2024 Performance and Business UpdateTipRanks.com - TipRanks
NanoVibronix reports highest Q1 revenue, eyes growth By Investing.com - Investing.com
NanoVibronix Issues Letter to Stockholders - Business Wire
NanoVibronix Issues Letter to Stockholders - Yahoo Finance
NanoVibronix partners with CB Medical for UroShield distribution - Investing.com
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield - Business Wire
NanoVibronix (STU:56R0) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Aug. 22, 2024) - GuruFocus.com
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):